Singulair 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.
MFDS item code 200307987 · Approved 2003.06.23 · Insurance code 073100301
Prevention of asthma and relief of allergic rhinitis symptoms
This medication helps to prevent and manage asthma and is used to relieve symptoms of seasonal and perennial allergic rhinitis.
The 4 mg granules of this medication can be taken orally as is or mixed with a small amount (about 5 mL) of soft food, breast milk, or porridge that is below room temperature. The packaging should not be opened until just before taking the medication, and after opening, it should be taken immediately (within 15 minutes) by mixing it into soft food, breast milk, or consumed in total. This medication can be taken regardless of meal time.
Children aged 2 to 5 years: Administer 1 dose of 4 mg montelukast orally once daily. Infants aged 12 months to under 2 years: Administer 1 dose of 4 mg of this medication orally in the evening. Infants aged 6 months to under 2 years: This medication
This drug may cause significant neuropsychiatric adverse effects, so if symptoms such as restlessness, aggression, anxiety, depression, hallucinations, or suicidal thoughts occur during treatment, consult a doctor immediately. Patients with allergies to this medication or its components should not take it, and if an allergic reaction occurs, treatment should be stopped immediately and a physician should be consulted. Various adverse reactions, such as fatigue, headache, dyspepsia, cough, and rash, may occur while taking this medication, so if symptoms persist or worsen, notify medical staff. This medication is not a treatment for acute asthma attacks, so appropriate emergency medication should be used during acute symptoms, and it should not be suddenly replaced for other steroids. In cases of exercise-induced bronchospasm, do not treat with this drug alone, and use inhaled bronchodilators as directed by a physician. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid these medications while taking this drug, and must consult a physician as necessary. This medication may rarely induce vasculitis symptoms related to eosinophilia; therefore, if respiratory symptoms worsen or skin rashes occur, notify medical staff immediately. No specific interactions have been reported when taken with other medications; however, caution and careful monitoring by a physician are needed when taken with drugs that induce liver metabolism. It should only be taken during pregnancy when absolutely necessary, and use during breastfeeding should be considered carefully. It is advisable not to use this medication in infants under 6 months old, as safety and efficacy have not been established. In case of overdose, since there is no specific antidote, general treatment and symptom observation are necessary, and medical attention should be sought immediately if symptoms appear. This medication is sensitive to light, so it should be opened just before administration and taken immediately after opening; it should be stored out of reach of children. This medication should be taken consistently even when there are no asthma symptoms, and if symptoms worsen or emergencies occur, consult medical staff immediately.
Hives, severe swelling (edema), angioedema, tightness in the chest, difficulty breathing, cold sweat, pallor, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attack, respiratory distress accompanied by cough and fever, respiratory problems, yellowing of the skin or eyes (jaundice)
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. It is also important to keep it in a tightly sealed container to prevent air exposure. This will help maintain the efficacy of the medication for a long time.
A white, homogeneous granule free from foreign substances
28 sachets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.